Corporate Governance25 Jun 2026, 05:40 pm
Windlas Biotech Closes Trading Window for Q1 FY27 Results
AI Summary
Windlas Biotech Ltd has announced the closure of its trading window for company securities. This closure will be effective from July 1, 2026, and will remain in effect until 48 hours after the unaudited financial results for the quarter ended June 30, 2026, are publicly disclosed. This measure is in accordance with the company's internal code of conduct for regulating trading activities.
Key Highlights
- Trading window to close from July 1, 2026.
- Closure is for the upcoming unaudited financial results.
- Window reopens 48 hours after results are published.
- Adheres to the company's insider trading code of conduct.
Price Impact
More from WINDLAS*